RecruitingPhase 2NCT05638360

Evaluation of the Curative Effect of Ru-Yi-Jin-Huang-Saan

Evaluation of the Efficacy of Ru-Yi-Jin-Huang-Saan on Colles' Fracture ---a Randomized, Double-blind, Placebo-controlled Trial


Sponsor

Changhua Christian Hospital

Enrollment

100 participants

Start Date

May 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to assess the efficacy and safety of Ru-Yi-Jin-Huang-Saan for the treatment of Colles' fracture.


Eligibility

Min Age: 20 YearsMax Age: 80 Years

Inclusion Criteria2

  • People who are over 20 years old and have no lack of mental ability can understand the content of the experiment and are willing to participate in it.
  • Patients with Colles' fracture receive surgical fixation(ORIF).

Exclusion Criteria5

  • People are unable to cooperate with experiments and fill out questionnaires.
  • Patients have wounds on the back of their wrists.
  • Patients are allergic to traditional Chinese medicine for external applications or have used other traditional Chinese medicine for external applications.
  • Patients have cancer, stroke, and systemic diseases such as severe anemia, thyroid disease, uncontrolled diabetes, etc.
  • Pregnant woman.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRu Yi Jin Huang Powder

Each patch contains 13g Ru Yi Jin Huang Powder and 10c.c. water.

DRUGPlacebo

Each patch contains 13g starch and 10c.c. water.


Locations(1)

Changhua Christian Hospital

Changhua, Changhua, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05638360


Related Trials